The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study

Barbara Skrzydło-Radomańska(Medical University of Lublin), Božena Cukrowská(Children's Memorial Health Institute), Beata Prozorow-Król(Medical University of Lublin), Ewelina Kanarek(Children's Memorial Health Institute), Agnieszka Sowińska(Great Ormond Street Hospital), Joanna B. Bierła(Children's Memorial Health Institute), Emilia Majsiak(Cardinal Stefan Wyszynski University in Warsaw), Halina Cichoż‐Lach

Nutrients

February 26, 2021

10.3390/nu13030756

Cited by 82

Related Papers

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

|The Lancet|2022|295

The Relationship between the Infant Gut Microbiota and Allergy. The Role of Bifidobacterium breve and Prebiotic Oligosaccharides in the Activation of Anti-Allergic Mechanisms in Early Life

|Nutrients|2020|169

Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease

|World Journal of Gastroenterology|2017|103

The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow’s Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study

|Nutrients|2021|97

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study

|Nutrients|2020|95